Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to compare the robotic-assisted laparoscopic surgery to the traditional laparoscopic surgery in endometrial cancer patients.

The study is prospective and the patients are randomised into two groups of 50 patients each. Randomisation is done with Minim-programme and patients age and Body mass index are taken into account.

The primary endpoint is the operation time. The number of patients in this study is based on the non-inferiority design. Presumption is that the operation time in robotic-assisted laparoscopy will be 25% longer.

Secondary endpoints include:

1. bleeding

2. complications

3. conversions

4. number of pelvic lymph nodes


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01466777
Study type Interventional
Source Tampere University Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date November 2010
Completion date September 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05036681 - A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma Phase 2
Completed NCT00377520 - A Trial for Patients With Advanced/Recurrent Endometrial Cancer Phase 2
Recruiting NCT05902988 - A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer Phase 1/Phase 2
Recruiting NCT06192017 - Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Completed NCT03899441 - Multimedia Aid Gynecologic Counseling and Consent N/A
Completed NCT02552121 - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors Phase 1/Phase 2
Completed NCT02001623 - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors Phase 1/Phase 2
Completed NCT02997553 - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery Phase 3
Suspended NCT03095664 - Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors N/A
Completed NCT01068483 - Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients Phase 1
Recruiting NCT03896113 - Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma Phase 2
Not yet recruiting NCT03570866 - PET/CT in the Management of Patients With Early Stage Endometrial Cancer
Completed NCT05246462 - The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients N/A
Withdrawn NCT04464967 - Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers Phase 1/Phase 2
Recruiting NCT05651282 - Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer Phase 4
Completed NCT06187558 - Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery
Completed NCT06312917 - Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer N/A
Active, not recruiting NCT03951415 - Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer Phase 2
Recruiting NCT04212910 - Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
Completed NCT02221076 - Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. N/A